Identification of germline variation that predicts progression free survival following chemotherapy for advanced ovarian cancer [ 2013 - 2015 ]

Research Grant

Researchers: A/Pr Stuart Macgregor (Principal investigator) ,  A/Pr Juliet French ,  Dr Jonathan Beesley ,  Dr Michelle Henderson ,  Prof Anna Defazio
View all 6 related researchers

Brief description Women diagnosed with ovarian cancer typically undergo surgery, followed by chemotherapy. However, the efficacy of chemotherapy varies widely, with some women responding well, whilst others are exposed to the toxic effects of a treatment that does them little good. We aim to identify the genes which explain why there are differences in response. This will lead to more individualised chemotherapy and improved outcomes for women with ovarian cancer.

Funding Amount $AUD 633,156.81

Funding Scheme Project Grants

Notes Standard Project Grant